Biotech Values

[DewDiligence]

RMTI -34% on revelation that Triferic=vaporware:

http://finance.yahoo.com/news/rockwell-medical-reports-fourth-quarter-210203353.html

“We obtained FDA approval for Triferic, scaled-up manufacturing and launched our novel iron replacement drug in September. We have been educating customers large and small about Triferic’s clinical and cost-saving benefits and its convenient in-center use. We have also strengthened the foundation for the drug’s commercial success by developing new packaging, which provides economic benefit to our customers and Rockwell, and it should be commercially available in about 8 weeks. Importantly, we are working with CMS to obtain transitional add-on payment for Triferic which, if obtained, should have a positive impact on market adoption.”

In other words, they aren't selling a material amount yet.